Covered recipient · General Payments record
ELIZABETH H EVERSMANN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$3,525.49
- Reported across 217 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $332.98 | 24 |
| Education | $99.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $138.98 | 14 |
| Lilly USA, LLC | $102.33 | 5 |
| Astellas Pharma US Inc | $99.99 | 1 |
| PFIZER INC. | $23.33 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.83 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.15 | 1 |
| ITI, Inc. | $16.98 | 1 |
| Acerta Pharma LLC | $16.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.08 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107084612 | CMS |
| ABBVIE INC. | $17.20 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107084614 | CMS |
| ABBVIE INC. | $9.10 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107084616 | CMS |
| ABBVIE INC. | $14.59 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107084618 | CMS |
| ABBVIE INC. | $6.72 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107084620 | CMS |
| ABBVIE INC. | $9.07 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107084622 | CMS |
| ABBVIE INC. | $7.24 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107084624 | CMS |
| ABBVIE INC. | $13.32 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107084626 | CMS |
| ABBVIE INC. | $18.13 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107084628 | CMS |
| ABBVIE INC. | $3.26 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107084630 | CMS |
| ABBVIE INC. | $5.14 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107084632 | CMS |
| ABBVIE INC. | $9.70 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107084634 | CMS |
| ABBVIE INC. | $8.00 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107084636 | CMS |
| ABBVIE INC. | $9.43 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107084638 | CMS |
| Astellas Pharma US Inc | $99.99 | 03/14/2024 | Education | Undisputed | 01/23/2026 | 1139505663 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.38 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105251564 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.98 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143443297 | CMS |
| Lilly USA, LLC | $17.28 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135624615 | CMS |
| Lilly USA, LLC | $20.31 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135579530 | CMS |
| Lilly USA, LLC | $18.81 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135550653 | CMS |
| Lilly USA, LLC | $24.31 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135579532 | CMS |
| Lilly USA, LLC | $21.62 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135618993 | CMS |
| Novartis Pharmaceuticals Corporation | $17.83 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086939433 | CMS |
| PFIZER INC. | $23.33 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131143643 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.15 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153503216 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.